Schedule 13G ownership disclosure
CLARUS THERAPEUTICS HXXXBANKRUPTCY EFF 030123
Security class unavailable · CUSIP: 18271L107
Event date: 2021-09-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,627,795
- Percent of class
- 7.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-116918
- Form type
- SC 13G
- Filer
- Bracebridge Capital, LLC
- CIK
- CIK 1426486
- Filed
- Sep 17, 2021
- Reporting period
- Sep 09, 2021
- Description
- Schedule 13G beneficial ownership